Silvia Uixeda-Cornejo

Sagunto, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Letter to the editor 'high persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study)'.

Letter to the editor 'high persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study)'.

Journal: Scandinavian journal of gastroenterology

Published: April 29, 2026

Remission and treatment persistence during sequential therapy in rheumatoid arthritis: results from the Estonian Biologic Treatment Registry.

Remission and treatment persistence during sequential therapy in rheumatoid arthritis: results from the Estonian Biologic Treatment Registry.

Journal: Rheumatology international

Published: March 27, 2026

Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety.

Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety.

Journal: Therapeutic advances in gastroenterology

Published: March 12, 2026

Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study".

Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study".

Journal: Intestinal research

Published: March 03, 2026

Comment on: Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study.

Comment on: Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study.

Journal: Italian journal of dermatology and venereology

Published: January 22, 2026

Letter to the Editor Regarding 'National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort Study'.

Letter to the Editor Regarding 'National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort Study'.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: January 04, 2026

Letter to the Editor "Use and Persistence of Beta 3-Adrenoceptor Agonists for the Treatment of Overactive Bladder".

Letter to the Editor "Use and Persistence of Beta 3-Adrenoceptor Agonists for the Treatment of Overactive Bladder".

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: January 02, 2026

How Adherence Shapes Persistence in Idiopathic Pulmonary Fibrosis Treatment: A Call for Real-World Insight.

How Adherence Shapes Persistence in Idiopathic Pulmonary Fibrosis Treatment: A Call for Real-World Insight.

Journal: Annals of the American Thoracic Society

Published: September 12, 2025

Letter to the Editor Regarding "Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis".

Letter to the Editor Regarding "Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis".

Journal: Inflammatory bowel diseases

Published: September 03, 2025

Letter to the editor regarding "Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort".

Letter to the editor regarding "Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort".

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: September 02, 2025

Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice.

Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: August 31, 2025

Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice.

Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: August 31, 2025

Showing 1-12 of 25

Last Updated: 09/26/2026